Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Overview

This article presents a protocol for isolating and expanding cytokine-induced killer T cells derived from peripheral blood mononuclear cells (PBMCs). It also demonstrates their cytotoxic effects against various cancer cells using flow cytometry.

Key Study Components

Area of Science

• Immunology
• Cancer Biology
• Cell Therapy

Background

• Cytokine-induced killer (CIK) cells are a promising therapeutic option for cancer treatment.
• Isolation and expansion of PBMC-derived CIK cells can enhance their cytotoxic potential.
• Flow cytometry is a valuable tool for assessing cell viability and cytotoxicity.
• Standardized protocols are essential for reproducibility in clinical and research settings.

Purpose of Study

• To optimize a method for the expansion of PBMC-derived CIK cells.
• To evaluate the cytotoxicity of these cells against hematological and solid tumors.
• To provide a standard operating procedure for technicians and clinicians.

Methods Used

• Preparation of CIK cells from PBMCs.
• Washing and centrifugation of CIK cells.
• Resuspension of cells in sterile PBS.
• Cell counting and viability testing using the trypan blue exclusion assay.

Main Results

• Successful isolation and expansion of CIK cells were achieved.
• CIK cells demonstrated significant cytotoxicity against cancer cells.
• The method provides a reliable approach for quantifying CIK cell potency.
• Flow cytometry effectively assessed the cytotoxic effects of CIK cells.

Conclusions

• The optimized protocol enhances the clinical applicability of CIK cells.
• This method can facilitate further research and clinical evaluations.
• Standardized procedures are crucial for consistent results in cell therapy.

Frequently Asked Questions